Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
He, Selin Hua
- Increase in Articles Published by Authors from Mainland Chinese Hospitals in High-Impact Journals:A Comparison between 2012 and 2017
Abstract Views :314 |
PDF Views:71
Authors
Mina Min Wu
1,
Joy Qingjiao Liao
1,
John Shibing Zhang
1,
Elva Kangyan Chen
1,
Selin Hua He
1,
Yuan-Yuan Zhang
2,
Harry Hua-Xiang Xia
3
Affiliations
1 Medjaden Bio-science Limited, Room 1201, Block D, Jinyuan World Center, 21 Yue Fei Street, Zhongshan Road, Jiang’an District, Wuhan, CN
2 Department of Pharmacology, West China School of Preclinical and Forensic Medicine, Sichuan University, 17 Section 3, Renmin Nanlu, Chengdu, CN
3 Department of Gastroenterology, the First Affiliated Hospital of Guangdong Pharmaceutical University, 19 Longlinxia Road, Yuexiu District, Guangzhou, CN
1 Medjaden Bio-science Limited, Room 1201, Block D, Jinyuan World Center, 21 Yue Fei Street, Zhongshan Road, Jiang’an District, Wuhan, CN
2 Department of Pharmacology, West China School of Preclinical and Forensic Medicine, Sichuan University, 17 Section 3, Renmin Nanlu, Chengdu, CN
3 Department of Gastroenterology, the First Affiliated Hospital of Guangdong Pharmaceutical University, 19 Longlinxia Road, Yuexiu District, Guangzhou, CN
Source
Current Science, Vol 117, No 11 (2019), Pagination: 1793-1799Abstract
The research outputs have rarely been studied in Mainland China. The present study aimed to analyse research articles published in high-impact journals (HIJs) by authors from Mainland Chinese hospitals in 2012 and 2017. All types of articles were searched in the PubMed and Embase data-bases. The durations were 1 January–31 December 2012 and 1 January–31 December 2017. Ten parameters were analysed. Overall, 205 and 871 articles were published in 2012 and 2017 respectively, in 198 HIJs. The proportion of articles published in journals with journal impact factor (JIF) > 25 was higher in 2017 than in 2012 (12.3% vs 9.8%). The number (proportion) of original articles increased from 146 (71.2%) in 2012 to 509 (58.4%) in 2017. There were 92 (44.9%) and 89 (43.4%) articles in basic and clinical research in 2012, whereas the numbers (proportions) were 409 (44.9%) and 230 (26.4%) respectively, in 2017. The number of articles acknowledging domestic (within China) and international (between Mainland China and other countries) cooperation in 2017 increased by almost seven-fold (281 vs 41) and eight-fold (289 vs 38) respectively. Funding acknowledgement was made in 85.4% and 75.8% of articles in 2012 and 2017 respectively. The number of articles published in HIJs by authors from Mainland Chinese hospitals has increased rapidly from 2012 to 2017, with only approximately 10% being published in journals with JIF > 25. The number of original articles on basic and clinical research has dramatically increased. Domestic and international cooperation and research funding are found to play an important role.Keywords
Biomedical Research, High-Impact Journals, Scientific Articles.Full Text
References
- Journal impact factor; http://ipscience-help.thomsonreuters.com/inCites2Live/indicatorsGroup/aboutHandbook/usingCitation-IndicatorsWisely/jif.html (accessed on 22 May 2019).
- Oh, H. C. and Lim, J. F., Is the journal impact factor a valid indicator of scientific value? Singapore Med. J., 2009, 50, 749–751.
- China’s achievements shine 2017 scientific research ‘world list’; http://www.xinhuanet.com/mrdx/2017-12/20/c_136838875.htm (accessed on 22 May 2019).
- ISI Journal Citation Reports, Institute for Scientific Information; http://isiknowledge.com (accessed on 22 May 2019).
- Cheng, T., Research in orthopaedics from China has thrived over the last decade: a bibliometric analysis of publication activity. Orthop. Traumatol.: Sur. Res., 2012, 98, 253–258.
- Wang, J. et al., Scientific publication in orthopedics journals from Chinese authors: a survey of 10-year survey of the literature. Eur. Spine J., 2015, 24, 1820–1825.
- Liao, Q. J. et al., Perceptions of Chinese biomedical researchers towards academic misconduct: a comparison between 2015 and 2010. Sci. Eng. Ethics, 2018, 24, 629–645.
- Statistical data with NSFC; http://www.nsfc.gov.cn/publish/portal0/tab505/ (accessed on 22 May 2019).
- Dan, F. and Yong, F., Role of SCI in the scientific research evaluation system of college-affiliated hospitals. Negative, 2016, 7, 56–59 (in Chinese).
- Sun, J. W., Liu, D., Wang, X. W. and Hou, H. Y., Science funding and SCI papers output: a comparative analysis on 10 countries. Stud. Sci. Sci., 2013, 31, 36–42 (in Chinese).
- Wang, X., Liu, D., Ding, K. and Wang, X., Science funding and research output: a study on 10 countries. Scientometrics, 2012, 91, 591–599.
- Chen, Q. and Liu, H., Scientific research funding input and high level international papers output: the empirical analysis based on the SCI papers of 6 countries. Forum on Science Technology in China, 2018.
- Zhang, Q. et al., Epidemiology of hepatitis B and hepatitis C infections and benefits of programs for hepatitis prevention in Northeastern China: a cross-sectional study. Clin. Infect. Dis., 2016, 62, 305–312.
- Cui, Y. and Jia, J., Update on epidemiology of hepatitis B and C in China. J. Gastroenterol. Hepatol. (Suppl. 1), 2013, 28, 7–10.
- Mok, T. S. et al., Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N. Engl. J. Med., 2017, 376, 629–640.
- Soria, J. C. et al., Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N. Engl. J. Med., 2018, 378, 113–125.
- Robson, M. et al., Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N. Engl. J. Med., 2017, 377, 523–533.
- Zhou, Y. et al., Tiotropium in early-stage chronic obstructive pulmonary disease. N. Engl. J. Med., 2017, 377, 923–935.
- Xie, Y. L. et al., Evaluation of a rapid molecular drug-susceptibility test for tuberculosis. N. Engl. J. Med., 2017, 377, 1043–1054.
- Zheng, M. X. et al., Trial of contralateral seventh cervical nerve transfer for spastic arm paralysis. N. Engl. J. Med., 2018, 378, 22–34.
- Chan, K. C. A. et al., Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N. Engl. J. Med., 2017, 377, 513–522.
- Zhang, L. et al., Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 379, 815–822.
- Lu, J. et al., Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet, 2017, 390, 2549–2558.
- Su, M. et al., Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet, 2017, 390, 2559–2568.
- Tan, J. et al., Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA – J. Am. Med. Assoc., 2012, 307, 1169–1177.
- Liu, Z. et al., Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA – J. Am. Med. Assoc., 2017, 317, 2493–2501.
- Lv, J. et al., Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the testing randomized clinical trial. JAMA – J. Am. Med. Assoc., 2017, 318, 432–442.
- Wang, H. et al., Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial. JAMA – J. Am. Med. Assoc., 2017, 318, 2190–2198.
- Wu, X. K. et al., Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial. JAMA – J. Am. Med. Assoc., 2017, 317, 2502–2514.